Loading…

Effects of Cyclic Adenosine 3' :5'-Monophosphate-Elevating Agents and Retinoic Acid on Differentiation in Retinoid-Deficient Tracheal Cultures

The ability of cyclic AMP-elevating agents to induce normal differentiation has been investigated in retinoid-deficient hamster tracheal epithelium in organ culture. Dibutyryl cAMP (dbcAMP) and other cAMP-regulating agents alone caused disappearance of keratin and regeneration of normal mucociliary...

Full description

Saved in:
Bibliographic Details
Published in:In Vitro Cellular & Developmental Biology 1985-12, Vol.21 (12), p.688-692
Main Authors: Schiff, Leonard J., Moore, Steven J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The ability of cyclic AMP-elevating agents to induce normal differentiation has been investigated in retinoid-deficient hamster tracheal epithelium in organ culture. Dibutyryl cAMP (dbcAMP) and other cAMP-regulating agents alone caused disappearance of keratin and regeneration of normal mucociliary epithelium in retinoid-deficient cultures. Incubation of retinoid-deficient cultures with dbcAMP, isoproterenol, and cholera toxin (CT) (without addition of exogenous retinoid) reversed keratinization in a dose-dependent manner. The ED50of cultures treated with dbcAMP was$4 \times 10^{-6} M$; ED50of isoproterenol was$7 \times 10_{-5} M$; and CT,$0.6 \mug/ml$. Phosphodiesterase inhibitors and other cAMP analogs were inactive. Dibutyryl cAMP in combination with theophylline enhanced normal differentiation. Retinoid-deficient tracheas pretreated for 20 h with$10^{-9} M$all-trans-retinoic acid (RA) responded to 10-6M dbcAMP by potentiating normal differentiation; this concentration of dbcAMP alone was inactive. Isoproterenol showed a similar response but to a lesser degree. These cAMP-elevating agents applied in combination with theophylline did not increase activity.
ISSN:0883-8364
2327-431X
1475-2689
DOI:10.1007/BF02620923